Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A SWOT Analysis Of AstraZeneca Plc And GlaxoSmithKline plc
Motley Fool
Thursday, November 14, 2013 - 10:30am
tags:
AstraZeneca, GSK
Eli Lilly to invest $700M to enhance global insulin manufacturing capacity
Yahoo/Fly on the Wall
Thursday, November 14, 2013 - 10:29am
tags:
Eli Lilly, drug manufacturing, insulin, diabetes
Intercept Pharma 3Q loss jumps on bigger charges
Yahoo/AP
Thursday, November 14, 2013 - 10:19am
tags:
earnings, Intercept Pharma
4 Healthcare Stock Stories Making Midweek Headlines
Wall St Cheat Sheet
Thursday, November 14, 2013 - 10:15am
tags:
BAX 855, Baxter International, plecanatide, Synergy Pharmaceuticals, layoffs, Transcept, NPS Pharmaceuticals, Gattex
Experimental bird flu vaccines show promise in early trials
Yahoo/Reuters
Thursday, November 14, 2013 - 8:57am
tags:
bird flu, Novartis, vaccines, Novavax, H7N9
Sanofi MS Drug’s Mixed Verdict From FDA Panel Puzzles Analysts
Bloomberg
Thursday, November 14, 2013 - 8:56am
tags:
Sanofi, multiple sclerosis, FDA, MS, Lemtrada, advisory panels
Vanda Pharma FDA Panel Live Blog
TheStreet.com
Thursday, November 14, 2013 - 8:53am
tags:
Vanda, FDA, advisory panels, tasimelteon, non-24 hour disorder, blindness
5 FDA-Approved Drugs That Disappointed Investors in 2013
Motley Fool
Wednesday, November 13, 2013 - 10:33pm
tags:
FDA, Amarin, Vivus, Dendreon, Arena Pharmaceuticals, Provenge, Vascepa, Iclusig, Ariad Pharmaceuticals, Belviq, Qsymia
FDA panel supports approval of Sanofi MS drug Lemtrada, with reservations
Yahoo/Reuters
Wednesday, November 13, 2013 - 5:36pm
tags:
FDA, advisory panels, Sanofi, Lemtrada, MS, multiple sclerosis
The Anti-Kickback Statute And The Affordable Care Act: A Law Enforcement Tool Suddenly Goes Missing
Forbes
Wednesday, November 13, 2013 - 12:51pm
tags:
Affordable Care Act, kickbacks, anti-kickback statute, JNJ
Pharmacyclics' Lymphoma Drug Receives FDA Approval
TheStreet.com
Wednesday, November 13, 2013 - 12:50pm
tags:
Pharmacyclics, FDA, Imbruvica, mantle cell lymphoma, ibrutinib
Senate Moves Closer To Passing Pharmacy Compounding Bill
Pharmalot
Wednesday, November 13, 2013 - 12:48pm
tags:
compounding pharmacies
U.S. heart guidelines may threaten hot new cholesterol drugs
Yahoo/Reuters
Wednesday, November 13, 2013 - 12:47pm
tags:
cholesterol, statins, PCSK9 inhibitors, Sanofi, Regeneron, Pfizer, Amgen
Celgene's Revlimid Makes Stronger Case for European Front-Line Approval
TheStreet.com
Wednesday, November 13, 2013 - 11:00am
tags:
Celgene, Revlimid, Europe, Multiple Myeloma
Dendreon Has Another Disaster Quarter
Seeking Alpha
Wednesday, November 13, 2013 - 10:59am
tags:
Dendreon, earnings
5 Private Biotechs Revolutionizing Medicine
Motley Fool
Wednesday, November 13, 2013 - 8:58am
tags:
Alvine Pharmaceuticals, AnaptysBio, CytomX, Parabon Nanolabs, Polyphor
Biopharma Alliances Will Be Needed For Cancer Drugs In The Cost Conscious Future
Forbes
Wednesday, November 13, 2013 - 8:54am
tags:
cancer, biotech, R&D
Cholesterol Guideline Changes Double Number on Treatments
Bloomberg
Wednesday, November 13, 2013 - 8:48am
tags:
cholesterol, statins, AstraZeneca, Merck, Pfizer
[video]Bristol-Myers Squibb's Radical Transformation
Motley Fool
Wednesday, November 13, 2013 - 8:47am
tags:
Bristol-Myers Squibb
Alzheimer’s Clues Sought Studying Link to Down Syndrome
Bloomberg
Wednesday, November 13, 2013 - 8:44am
tags:
Downs Syndrome, JNJ, Alzheimer's disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.